Mycophenolate mofetil and Cell death - a phase IV clinical study of FDA data

Summary:

Cell death is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Envarsus Xr, and have Immunodeficiency disorders.

The study is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,460 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

On Jul, 12, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 41 people (0.04%) died.

Could Mycophenolate mofetil cause Cell death?

Among these 41 people:

How long have people been on Mycophenolate mofetil when they died? *

What is the gender of people who died when taking Mycophenolate mofetil? *

female: 62.5 %
male: 37.5 %

What is the age of people who died when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

What are other side effects people have before they died? *

Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 34 people, 82.93%
Transplant Rejection (a transplant material is not worked): 22 people, 53.66%
Ascites (accumulation of fluid in the abdominal cavity): 19 people, 46.34%
Renal Impairment (severely reduced kidney function): 14 people, 34.15%
Liver Function Test Abnormal: 13 people, 31.71%
Hyperglycemia (high blood sugar): 12 people, 29.27%
Diarrhea: 12 people, 29.27%
Diabetes: 9 people, 21.95%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 17.07%
Tremor (trembling or shaking movements in one or more parts of your body): 5 people, 12.20%

What are the existing conditions these people have? *

Immunodeficiency Disorders: 19 people, 46.34%
Stress And Anxiety: 12 people, 29.27%
Hypoglycemia (low blood sugar): 10 people, 24.39%
Diabetes: 5 people, 12.20%
Venoocclusive Liver Disease (small veins in the liver are obstructed): 3 people, 7.32%
Cytomegalovirus Infection: 3 people, 7.32%
Transplant Rejection (a transplant material is not worked): 2 people, 4.88%
Cytomegalovirus Test Positive: 2 people, 4.88%
Liver Transplant Rejection (failure of liver transplant): 1 person, 2.44%
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)): 1 person, 2.44%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,460 reports)

Expand to all the drugs that have ingredients of mycophenolate mofetil:

Cell death and drugs with ingredients of mycophenolate mofetil (30 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cell death:

Cell death (211 drugs)

Browse all the conditions that are associated with Cell death:

Cell death (331 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.